Abstract
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism was shown to strongly affect BDNF function, but its role in modulating gray matter damage in multiple sclerosis (MS) patients is still not clear. Given BDNF relevance on the hippocampus, we aimed to explore BDNF Val66Met polymorphism effect on hippocampal subfield volumes and its role in cognitive functioning in MS patients. Using a 3T scanner, we obtained dual-echo and 3DT1-weighted sequences from 50 MS patients and 15 healthy controls (HC) consecutively enrolled. MS patients also underwent genotype analysis of BDNF, neurological and neuropsychological evaluation. Hippocampal subfields were segmented by using Freesurfer. The BDNF Val66Met polymorphism was found in 22 MS patients (44%). Compared to HC, MS patients had lower volume in: bilateral hippocampus-amygdala transition area (HATA); cornus ammonis (CA)1, granule cell layer of dentate gyrus (GCL-DG), CA4 and CA3 of the left hippocampal head; molecular layer (ML) of the left hippocampal body; presubiculum of right hippocampal body and right fimbria. Compared to BDNF Val66Val, Val66Met MS patients had higher volume in bilateral hippocampal tail; CA1, ML, CA3, CA4, and GCL-DG of left hippocampal head; CA1, ML, and CA3 of the left hippocampal body; left HATA and presubiculum of the right hippocampal head. In MS patients, higher lesion burden was associated with lower volume of presubiculum of right hippocampal body; lower volume of left hippocampal tail was associated with worse visuospatial memory performance; lower volume of left hippocampal head with worse performance in semantic fluency. Our findings suggest the BNDF Val66Met polymorphism may have a protective role in MS patients against both hippocampal atrophy and cognitive impairment. BDNF genotype might be a potential biomarker for predicting cognitive prognosis, and an interesting target to study for neuroprotective strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The dataset used and analyzed during the current study is available from the corresponding Author on reasonable request.
References
Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19:860–71.
Rocca MA, De Meo E, Filippi M. Functional MRI in investigating cognitive impairment in multiple sclerosis. Acta Neurol Scand. 2016;134:39–46. Suppl 200
Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol. 2001;63:71–124.
Hartmann M, Heumann R, Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 2001;20:5887–97.
Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14:7–23.
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257–69.
Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004;24:4401–11.
Bimonte-Nelson HA, Hunter CL, Nelson ME, Granholm AC. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav Brain Res. 2003;139:47–57.
Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003;23:6690–4.
Hajek T, Kopecek M, Höschl C. Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. World J Biol Psychiatry. 2012;13:178–87.
Stadelmann C, Kerschensteiner M, Misgeld T, Brück W, Hohlfeld R, Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 2002;125:75–85.
Ramasamy DP, Ramanathan M, Cox JL, Antulov R, Weinstock-Guttman B, Bergsland N, et al. Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: a voxel-based morphometry study. Pathophysiology 2011;18:53–60.
Zivadinov R, Weinstock-Guttman B, Benedict R, Tamaño-Blanco M, Hussein S, Abdelrahman N, et al. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet. 2007;16:2659–68.
Liguori M, Fera F, Gioia MC, Valentino P, Manna I, Condino F, et al. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis. Genes Brain Behav. 2007;6:177–83.
Dinacci D, Tessitore A, Russo A, De Bonis ML, Lavorgna L, Picconi O, et al. BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurological Sci. 2011;32:117–23.
Geurts JJ, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007;66:819–27.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014;83:278–86.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162–73.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52.
Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, et al. The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler. 2006;12:787–93.
Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643.
De Meo E, Portaccio E, Giorgio A, Ruano L, Goretti B, Niccolai C, et al. Identifying the distinct cognitive phenotypes in multiple sclerosis. JAMA Neurol. 2021;78:414–25.
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9.
Bagnoli S, Nacmias B, Tedde A, Guarnieri BM, Cellini E, Petruzzi C, et al. Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer’s disease in Italy. Ann Neurol. 2004;55:447–8.
Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CA. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010;32:223–8.
Iglesias JE, Augustinack JC, Nguyen K, Player CM, Player A, Wright M, et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. Neuroimage 2015;115:117–37.
Fischl B. FreeSurfer. NeuroImage 2012;62:774–81.
Samann PG, Iglesias JE, Gutman B, Grotegerd D, Leenings R, Flint C, et al. FreeSurfer-based segmentation of hippocampal subfields: a review of methods and applications, with a novel quality control procedure for ENIGMA studies and other collaborative efforts. Hum Brain Mapp. 2020;1–27.
Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131:1134–41.
Cacciaguerra L, Pagani E, Mesaros S, Dackovic J, Dujmovic-Basuroski I, Drulovic J, et al. Dynamic volumetric changes of hippocampal subfields in clinically isolated syndrome patients: A 2-year MRI study. Mult Scler. 2019;25:1232–42.
Rocca MA, Barkhof F, De Luca J, Frisen J, Geurts JJG, Hulst HE, et al. The hippocampus in multiple sclerosis. Lancet Neurol. 2018;17:918–26.
Longoni G, Rocca MA, Pagani E, Riccitelli GC, Colombo B, Rodegher M, et al. Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS. Brain Struct Funct. 2015;220:435–44.
Gold SM, Kern KC, O’Connor MF, Montag MJ, Kim A, Yoo YS, et al. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry. 2010;68:553–9.
Wang X, Pal R, Chen XW, Limpeanchob N, Kumar KN, Michaelis EK. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. Brain Res Mol Brain Res. 2005;140:120–6.
Vallejo-Illarramendi A, Domercq M, Pérez-Cerdá F, Ravid R, Matute C. Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis. 2006;21:154–64.
Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol. 2009;19:238–53.
Planche V, Koubiyr I, Romero JE, Manjon JV, Coupé P, Deloire M, et al. Regional hippocampal vulnerability in early multiple sclerosis: dynamic pathological spreading from dentate gyrus to CA1. Hum Brain Mapp. 2018;39:1814–24.
Duvernoy H, Cattin F, Risold P-Y Anatomy. In: Duvernoy HM, Cattin F, Risold P-Y, editors. The human hippocampus: functional anatomy, vascularization and serial sections with MRI. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. p. 39–68.
Haukvik UK, Gurholt TP, Nerland S, Elvsåshagen T, Akudjedu TN, Alda M, et al. In vivo hippocampal subfield volumes in bipolar disorder—A mega-analysis from The Enhancing Neuro Imaging Genetics through Meta-Analysis Bipolar Disorder Working Group. Human Brain Mapping. 2020;1–14.
O’Mara SM, Commins S, Anderson M, Gigg J. The subiculum: a review of form, physiology and function. Prog Neurobiol. 2001;64:129–55.
Ishihara Y, Fukuda T. Immunohistochemical investigation of the internal structure of the mouse subiculum. Neuroscience 2016;337:242–66.
Fudge JL, deCampo DM, Becoats KT. Revisiting the hippocampal–amygdala pathway in primates: association with immature-appearing neurons. Neuroscience 2012;212:104–19.
Kishi T, Tsumori T, Yokota S, Yasui Y. Topographical projection from the hippocampal formation to the amygdala: a combined anterograde and retrograde tracing study in the rat. J Comp Neurol. 2006;496:349–68.
Toda T, Parylak SL, Linker SB, Gage FH. The role of adult hippocampal neurogenesis in brain health and disease. Mol Psychiatry. 2019;24:67–87.
Kuipers SD, Tiron A, Soule J, Messaoudi E, Trentani A, Bramham CR. Selective survival and maturation of adult-born dentate granule cells expressing the immediate early gene Arc/Arg3.1. PLoS One. 2009;4:e4885.
Katoh-Semba R, Asano T, Ueda H, Morishita R, Takeuchi IK, Inaguma Y, et al. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. Faseb j 2002;16:1328–30.
Sairanen M, Lucas G, Ernfors P, Castrén M, Castrén E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 2005;25:1089–94.
Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S. Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol. 2005;192:348–56.
Schmidt HD, Duman RS. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010;35:2378–91.
Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002;22:3251–61.
Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14:401–16.
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006;314:140–3.
Zivadinov R, Bergsland N, Dolezal O, Hussein S, Seidl Z, Dwyer MG, et al. Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years. AJNR Am J Neuroradiol. 2013;34:1931–9.
Sarchielli P, Greco L, Stipa A, Floridi A, Gallai V. Brain-derived neurotrophic factor in patients with multiple sclerosis. J Neuroimmunol 2002;132:180–8.
Nociti V, Santoro M, Quaranta D, Losavio FA, De Fino C, Giordano R, et al. BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression. PLoS One. 2018;13:e0206140.
Black IB. Trophic regulation of synaptic plasticity. J Neurobiol 1999;41:108–18.
Narisawa-Saito M, Iwakura Y, Kawamura M, Araki K, Kozaki S, Takei N, et al. Brain-derived neurotrophic factor regulates surface expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptors by enhancing the N-ethylmaleimide-sensitive factor/GluR2 interaction in developing neocortical neurons. J Biol Chem 2002;277:40901–10.
Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001;294:1945–8.
Hasselmo ME, McClelland JL. Neural models of memory. Curr Opin Neurobiol. 1999;9:184–8.
Naber PA, Witter MP, Lopes, Silva FH. Networks of the hippocampal memory system of the rat. The pivotal role of the subiculum. Ann N. Y Acad Sci. 2000;911:392–403.
El-Gaby M, Shipton OA, Paulsen O. Synaptic plasticity and memory: new insights from hippocampal left-right asymmetries. Neuroscientist 2015;21:490–502.
Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, et al. Grey matter loss in relapsing–remitting multiple sclerosis: a voxel-based morphometry study. NeuroImage 2006;29:859–67.
Wolbers T, Dudchenko P, Wood E. Spatial memory—a unique window into healthy and pathological aging. Front in Aging Neurosci. 2014;6:35.
Burgess N, Maguire EA, O’Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002;35:625–41.
Maguire EA, Burgess N, Donnett JG, Frackowiak RSJ, Frith CD, O’Keefe J. Knowing where and getting there: a human navigation network. Science 1998;280:921–4.
Spiers HJ, Burgess N, Maguire EA, Baxendale SA, Hartley T, Thompson PJ, et al. Unilateral temporal lobectomy patients show lateralized topographical and episodic memory deficits in a virtual town. Brain 2001;124:2476–89.
Doeller CF, King JA, Burgess N. Parallel striatal and hippocampal systems for landmarks and boundaries in spatial memory. Proc Natl Acad Sci. 2008;105:5915.
Iglói K, Doeller CF, Berthoz A, Rondi-Reig L, Burgess N. Lateralized human hippocampal activity predicts navigation based on sequence or place memory. Proc Natl Acad Sci USA. 2010;107:14466–71.
Eichenbaum H. Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron 2004;44:109–20.
Hartley T, Maguire EA, Spiers HJ, Burgess N. The well-worn route and the path less traveled: distinct neural bases of route following and wayfinding in humans. Neuron 2003;37:877–88.
Ghaem O, Mellet E, Crivello F, Tzourio N, Mazoyer B, Berthoz A, et al. Mental navigation along memorized routes activates the hippocampus, precuneus, and insula. Neuroreport 1997;8:739–44.
Kumaran D, Maguire EA. Match–mismatch processes underlie human hippocampal responses to associative novelty. J Neurosci. 2007;27:8517–24.
Nielson DM, Smith TA, Sreekumar V, Dennis S, Sederberg PB. Human hippocampus represents space and time during retrieval of real-world memories. Proc Natl Acad Sci. 2015;112:11078–83.
Zeidman P, Mullally SL, Maguire EA. Constructing, perceiving, and maintaining scenes: hippocampal activity and connectivity. Cereb Cortex. 2015;25:3836–55.
Persson J, Spreng RN, Turner G, Herlitz A, Morell A, Stening E, et al. Sex differences in volume and structural covariance of the anterior and posterior hippocampus. Neuroimage 2014;99:215–25.
Suzuki WA, Amaral DG. Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents. J Comp Neurol 1994;350:497–533.
Moscovitch M, Cabeza R, Winocur G, Nadel L. Episodic memory and beyond: the hippocampus and neocortex in transformation. Annu Rev Psychol. 2016;67:105–34.
Acknowledgements
We thank Dr. Raffaello Bonacchi from Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute for revising the manuscript.
Author information
Authors and Affiliations
Contributions
Ermelinda De Meo contributed to study concept and design, drafting/revising the manuscript, data analysis; Emilio Portaccio contributed to patient recruitment and clinical assessment; Elio Prestipino contributed to patient recruitment, clinical assessment and data analysis; Benedetta Nacmias contributed to genetic analysis; Silvia Bagnoli contributed to genetic analysis; Lorenzo Razzolini contributed to patient recruitment and clinical assessment; Luisa Pastò contributed to patient recruitment and clinical assessment; Claudia Niccolai contributed to neuropsychological assessment; Benedetta Goretti contributed to neuropsychological assessment; Angelo Bellinvia contributed to patient recruitment and clinical assessment; Mattia Fonderico contributed to patient recruitment and clinical assessment; Antonio Giorgio contributed to MRI data analysis; Maria Laura Stromillo contributed to MRI data analysis; Massimo Filippi contributed to study drafting/revising the manuscript; Sandro Sorbi contributed to study drafting/revising the manuscript; Nicola De Stefano contributed to study drafting/revising the manuscript; Maria Pia Amato, MD contributed to study concept and drafting/revising the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
Approval was received from Ethics Committee on human experimentation of the University of Florence, and written informed consent was obtained from all participants prior to study enrollment.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Meo, E., Portaccio, E., Prestipino, E. et al. Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients. Mol Psychiatry 27, 1010–1019 (2022). https://doi.org/10.1038/s41380-021-01345-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-021-01345-1